News

Alderaan Biotechnology raises € 18.5 million in the framework 706 424 fsena

Alderaan Biotechnology raises € 18.5 million in the framework

Alderaan Biotechnology, a preclinical stage company focused on monoclonal antibodies development for the treatment of…

read more